JP4268556B2 - ｓＨＳＰｓを含むタンパク質分解防止用組成物およびこれを用いた２次元ゲル電気泳動法 - Google Patents
ｓＨＳＰｓを含むタンパク質分解防止用組成物およびこれを用いた２次元ゲル電気泳動法 Download PDFInfo
- Publication number
- JP4268556B2 JP4268556B2 JP2004108476A JP2004108476A JP4268556B2 JP 4268556 B2 JP4268556 B2 JP 4268556B2 JP 2004108476 A JP2004108476 A JP 2004108476A JP 2004108476 A JP2004108476 A JP 2004108476A JP 4268556 B2 JP4268556 B2 JP 4268556B2
- Authority
- JP
- Japan
- Prior art keywords
- derived
- ibpa
- shsps
- ibpb
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 108091052270 small heat shock protein (HSP20) family Proteins 0.000 title claims abstract description 69
- 239000000203 mixture Substances 0.000 title claims abstract description 43
- 230000017854 proteolysis Effects 0.000 title claims abstract description 22
- 102000042290 small heat shock protein (HSP20) family Human genes 0.000 title claims abstract 4
- 238000000539 two dimensional gel electrophoresis Methods 0.000 title claims description 75
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 139
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 130
- 238000000034 method Methods 0.000 claims abstract description 47
- 238000001502 gel electrophoresis Methods 0.000 claims abstract 4
- 102000008063 Small Heat-Shock Proteins Human genes 0.000 claims description 66
- 241000588724 Escherichia coli Species 0.000 claims description 34
- 101150050258 Hsp26 gene Proteins 0.000 claims description 34
- 108091005804 Peptidases Proteins 0.000 claims description 28
- 102000035195 Peptidases Human genes 0.000 claims description 27
- 239000004365 Protease Substances 0.000 claims description 24
- 210000004027 cell Anatomy 0.000 claims description 22
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 17
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 17
- 239000003112 inhibitor Substances 0.000 claims description 16
- 238000001962 electrophoresis Methods 0.000 claims description 15
- 241000589516 Pseudomonas Species 0.000 claims description 10
- 108010026552 Proteome Proteins 0.000 claims description 8
- 230000015556 catabolic process Effects 0.000 claims description 6
- 238000006731 degradation reaction Methods 0.000 claims description 6
- 210000003527 eukaryotic cell Anatomy 0.000 claims description 6
- 102000002812 Heat-Shock Proteins Human genes 0.000 claims description 5
- 108010004889 Heat-Shock Proteins Proteins 0.000 claims description 5
- 210000001236 prokaryotic cell Anatomy 0.000 claims description 5
- 241000607479 Yersinia pestis Species 0.000 claims 9
- 241000607762 Shigella flexneri Species 0.000 claims 5
- 241000589155 Agrobacterium tumefaciens Species 0.000 claims 4
- 241000219195 Arabidopsis thaliana Species 0.000 claims 4
- 241000710177 Citrus tristeza virus Species 0.000 claims 4
- 101100339887 Drosophila melanogaster Hsp27 gene Proteins 0.000 claims 4
- 101150096895 HSPB1 gene Proteins 0.000 claims 4
- 102100039165 Heat shock protein beta-1 Human genes 0.000 claims 4
- 241000590002 Helicobacter pylori Species 0.000 claims 4
- 101001036709 Homo sapiens Heat shock protein beta-1 Proteins 0.000 claims 4
- 241000203407 Methanocaldococcus jannaschii Species 0.000 claims 4
- 241000186362 Mycobacterium leprae Species 0.000 claims 4
- 241000187479 Mycobacterium tuberculosis Species 0.000 claims 4
- 241000589956 Pirellula Species 0.000 claims 4
- 240000004713 Pisum sativum Species 0.000 claims 4
- 235000010582 Pisum sativum Nutrition 0.000 claims 4
- 241000223960 Plasmodium falciparum Species 0.000 claims 4
- 241000589517 Pseudomonas aeruginosa Species 0.000 claims 4
- 241000589776 Pseudomonas putida Species 0.000 claims 4
- 241001138501 Salmonella enterica Species 0.000 claims 4
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 claims 4
- 241001223867 Shewanella oneidensis Species 0.000 claims 4
- 241000589196 Sinorhizobium meliloti Species 0.000 claims 4
- 241000187432 Streptomyces coelicolor Species 0.000 claims 4
- 241000205091 Sulfolobus solfataricus Species 0.000 claims 4
- 241000204673 Thermoplasma acidophilum Species 0.000 claims 4
- 241001453191 Thermosynechococcus vulcanus Species 0.000 claims 4
- 102000005735 beta-Crystallins Human genes 0.000 claims 4
- 108010070654 beta-Crystallins Proteins 0.000 claims 4
- 229940037467 helicobacter pylori Drugs 0.000 claims 4
- 101100071585 Caenorhabditis elegans hsp-16.2 gene Proteins 0.000 claims 3
- 241000204641 Methanopyrus kandleri Species 0.000 claims 3
- 241000187747 Streptomyces Species 0.000 claims 3
- 241000186339 Thermoanaerobacter Species 0.000 claims 3
- 241000204675 Methanopyrus Species 0.000 claims 2
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 claims 2
- 241000253373 Caldanaerobacter subterraneus subsp. tengcongensis Species 0.000 claims 1
- 241000219843 Pisum Species 0.000 claims 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 1
- 241000607142 Salmonella Species 0.000 claims 1
- 108010088928 Small Heat-Shock Proteins Proteins 0.000 claims 1
- 241000194017 Streptococcus Species 0.000 claims 1
- 230000002265 prevention Effects 0.000 abstract description 2
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 146
- 102000008100 Human Serum Albumin Human genes 0.000 description 82
- 108091006905 Human Serum Albumin Proteins 0.000 description 82
- 108090000631 Trypsin Proteins 0.000 description 37
- 102000004142 Trypsin Human genes 0.000 description 37
- 239000012588 trypsin Substances 0.000 description 37
- 241001302584 Escherichia coli str. K-12 substr. W3110 Species 0.000 description 34
- 108010067770 Endopeptidase K Proteins 0.000 description 29
- 239000000499 gel Substances 0.000 description 27
- 230000009089 cytolysis Effects 0.000 description 22
- 210000002966 serum Anatomy 0.000 description 20
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 17
- 235000019419 proteases Nutrition 0.000 description 17
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 15
- 241000320117 Pseudomonas putida KT2440 Species 0.000 description 14
- 239000013612 plasmid Substances 0.000 description 14
- WRDABNWSWOHGMS-UHFFFAOYSA-N AEBSF hydrochloride Chemical compound Cl.NCCC1=CC=C(S(F)(=O)=O)C=C1 WRDABNWSWOHGMS-UHFFFAOYSA-N 0.000 description 13
- 230000000694 effects Effects 0.000 description 13
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 8
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 7
- 239000004202 carbamide Substances 0.000 description 7
- 239000013611 chromosomal DNA Substances 0.000 description 7
- 230000002401 inhibitory effect Effects 0.000 description 7
- 238000001155 isoelectric focusing Methods 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 102000009027 Albumins Human genes 0.000 description 6
- 108010088751 Albumins Proteins 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 108020004414 DNA Proteins 0.000 description 5
- 102000007562 Serum Albumin Human genes 0.000 description 5
- 108010071390 Serum Albumin Proteins 0.000 description 5
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 5
- 239000007983 Tris buffer Substances 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000002068 genetic effect Effects 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 5
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 5
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 4
- 230000002776 aggregation Effects 0.000 description 3
- 238000004220 aggregation Methods 0.000 description 3
- 238000004925 denaturation Methods 0.000 description 3
- 230000036425 denaturation Effects 0.000 description 3
- 230000008642 heat stress Effects 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 108010030844 2-methylcitrate synthase Proteins 0.000 description 2
- UMCMPZBLKLEWAF-BCTGSCMUSA-N 3-[(3-cholamidopropyl)dimethylammonio]propane-1-sulfonate Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCC[N+](C)(C)CCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 UMCMPZBLKLEWAF-BCTGSCMUSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 102000004506 Blood Proteins Human genes 0.000 description 2
- 108010017384 Blood Proteins Proteins 0.000 description 2
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 2
- 108010071536 Citrate (Si)-synthase Proteins 0.000 description 2
- 102000006732 Citrate synthase Human genes 0.000 description 2
- 102000013460 Malate Dehydrogenase Human genes 0.000 description 2
- 108010026217 Malate Dehydrogenase Proteins 0.000 description 2
- RDFCSSHDJSZMTQ-ZDUSSCGKSA-N Tos-Lys-CH2Cl Chemical compound CC1=CC=C(S(=O)(=O)N[C@@H](CCCCN)C(=O)CCl)C=C1 RDFCSSHDJSZMTQ-ZDUSSCGKSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000006167 equilibration buffer Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- TWADEBCIPVNACR-ZDUSSCGKSA-N (2s)-2-(n-(4-methylphenyl)sulfonylanilino)propanoic acid Chemical compound C=1C=C(C)C=CC=1S(=O)(=O)N([C@@H](C)C(O)=O)C1=CC=CC=C1 TWADEBCIPVNACR-ZDUSSCGKSA-N 0.000 description 1
- VADKRMSMGWJZCF-UHFFFAOYSA-N 2-bromophenol Chemical compound OC1=CC=CC=C1Br VADKRMSMGWJZCF-UHFFFAOYSA-N 0.000 description 1
- PGPBBDLLMZHPIX-UHFFFAOYSA-N 3-amino-1-phenylpropane-1-sulfonyl fluoride Chemical compound NCCC(S(F)(=O)=O)C1=CC=CC=C1 PGPBBDLLMZHPIX-UHFFFAOYSA-N 0.000 description 1
- 208000002109 Argyria Diseases 0.000 description 1
- 238000009010 Bradford assay Methods 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 101150105338 HSP18.1 gene Proteins 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- MQUQNUAYKLCRME-INIZCTEOSA-N N-tosyl-L-phenylalanyl chloromethyl ketone Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N[C@H](C(=O)CCl)CC1=CC=CC=C1 MQUQNUAYKLCRME-INIZCTEOSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 108700036708 Pyrococcus furiosus small heat shock Proteins 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 101100339886 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) HSP26 gene Proteins 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000004931 aggregating effect Effects 0.000 description 1
- 102000007362 alpha-Crystallins Human genes 0.000 description 1
- 108010007908 alpha-Crystallins Proteins 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 210000001557 animal structure Anatomy 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- PXXJHWLDUBFPOL-UHFFFAOYSA-N benzamidine Chemical compound NC(=N)C1=CC=CC=C1 PXXJHWLDUBFPOL-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000008004 cell lysis buffer Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- BULLHNJGPPOUOX-UHFFFAOYSA-N chloroacetone Chemical compound CC(=O)CCl BULLHNJGPPOUOX-UHFFFAOYSA-N 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 239000003398 denaturant Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 210000003000 inclusion body Anatomy 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- PGLTVOMIXTUURA-UHFFFAOYSA-N iodoacetamide Chemical compound NC(=O)CI PGLTVOMIXTUURA-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000003712 lysosome Anatomy 0.000 description 1
- 230000001868 lysosomic effect Effects 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 238000012261 overproduction Methods 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000004845 protein aggregation Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000012192 staining solution Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 210000003934 vacuole Anatomy 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2003-0062756A KR100516389B1 (ko) | 2003-09-08 | 2003-09-08 | 작은 열 충격 단백질을 함유하는 단백질 분해 방지용조성물 및 이를 이용한 이차원 전기영동법 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005084048A JP2005084048A (ja) | 2005-03-31 |
| JP2005084048A5 JP2005084048A5 (OSRAM) | 2005-08-11 |
| JP4268556B2 true JP4268556B2 (ja) | 2009-05-27 |
Family
ID=36241956
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004108476A Expired - Fee Related JP4268556B2 (ja) | 2003-09-08 | 2004-03-31 | ｓＨＳＰｓを含むタンパク質分解防止用組成物およびこれを用いた２次元ゲル電気泳動法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7148334B2 (OSRAM) |
| EP (1) | EP1664094B1 (OSRAM) |
| JP (1) | JP4268556B2 (OSRAM) |
| KR (1) | KR100516389B1 (OSRAM) |
| CN (1) | CN1839151B (OSRAM) |
| AT (1) | ATE414101T1 (OSRAM) |
| AU (1) | AU2003284750B2 (OSRAM) |
| CA (1) | CA2537880C (OSRAM) |
| DE (1) | DE60324712D1 (OSRAM) |
| WO (1) | WO2005023847A1 (OSRAM) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2005332120B2 (en) * | 2005-05-23 | 2010-08-26 | Korea Advanced Institute Of Science And Technology | Method for preparing a target protein using the sHSPs |
| CN121160589A (zh) * | 2025-11-21 | 2025-12-19 | 齐鲁工业大学(山东省科学院) | 一种无抗生素标签诱导型耐盐类球红细菌工程菌及其应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4239969A1 (de) * | 1992-11-27 | 1994-06-01 | Boehringer Mannheim Gmbh | Verfahren zur Stabilisierung von Proteinen |
| US5837251A (en) * | 1995-09-13 | 1998-11-17 | Fordham University | Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases |
| US5993627A (en) * | 1997-06-24 | 1999-11-30 | Large Scale Biology Corporation | Automated system for two-dimensional electrophoresis |
| US6554991B1 (en) * | 1997-06-24 | 2003-04-29 | Large Scale Proteomics Corporation | Automated system for two-dimensional electrophoresis |
| AU2001236726A1 (en) * | 2000-02-08 | 2001-08-20 | The Regents Of The University Of Michigan | Protein separation and display |
| CA2409347C (en) * | 2000-04-14 | 2010-03-30 | Frank T. Robb | Enhanced protein thermostability and temperature resistance |
| WO2002090966A1 (en) | 2001-05-10 | 2002-11-14 | Large Scale Proteomics Corporation | Automated apparatus for separating a biological sample from a two dimensional electrophoresis gel |
| US20050064545A1 (en) * | 2002-01-07 | 2005-03-24 | Demarco Ario | Recombinant protein expression |
-
2003
- 2003-09-08 KR KR10-2003-0062756A patent/KR100516389B1/ko not_active Expired - Fee Related
- 2003-11-24 DE DE60324712T patent/DE60324712D1/de not_active Expired - Lifetime
- 2003-11-24 WO PCT/KR2003/002539 patent/WO2005023847A1/en not_active Ceased
- 2003-11-24 AT AT03774298T patent/ATE414101T1/de not_active IP Right Cessation
- 2003-11-24 EP EP03774298A patent/EP1664094B1/en not_active Expired - Lifetime
- 2003-11-24 CN CN2003801104474A patent/CN1839151B/zh not_active Expired - Fee Related
- 2003-11-24 CA CA2537880A patent/CA2537880C/en not_active Expired - Lifetime
- 2003-11-24 AU AU2003284750A patent/AU2003284750B2/en not_active Ceased
-
2004
- 2004-03-02 US US10/791,059 patent/US7148334B2/en not_active Expired - Fee Related
- 2004-03-31 JP JP2004108476A patent/JP4268556B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1664094A1 (en) | 2006-06-07 |
| CN1839151A (zh) | 2006-09-27 |
| EP1664094A4 (en) | 2006-09-27 |
| US7148334B2 (en) | 2006-12-12 |
| DE60324712D1 (de) | 2008-12-24 |
| CN1839151B (zh) | 2011-02-09 |
| ATE414101T1 (de) | 2008-11-15 |
| CA2537880A1 (en) | 2005-03-17 |
| AU2003284750B2 (en) | 2009-09-10 |
| US20050123994A1 (en) | 2005-06-09 |
| JP2005084048A (ja) | 2005-03-31 |
| KR100516389B1 (ko) | 2005-09-23 |
| KR20050025819A (ko) | 2005-03-14 |
| EP1664094B1 (en) | 2008-11-12 |
| WO2005023847A1 (en) | 2005-03-17 |
| AU2003284750A1 (en) | 2005-03-29 |
| CA2537880C (en) | 2011-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Whitney et al. | The gene for the ribulose-1, 5-bisphosphate carboxylase/oxygenase (Rubisco) small subunit relocated to the plastid genome of tobacco directs the synthesis of small subunits that assemble into Rubisco | |
| AU762993C (en) | Constitutive maize promoters | |
| AU639891B2 (en) | Expression cassette for plants | |
| US7189570B2 (en) | Putrescine-n-methyltransferase promoter | |
| CN116507728A (zh) | 大豆中的豆血红蛋白 | |
| JP4268556B2 (ja) | ｓＨＳＰｓを含むタンパク質分解防止用組成物およびこれを用いた２次元ゲル電気泳動法 | |
| CN109295071B (zh) | 一种水稻花器官发育调控基因peh1及其编码的蛋白质和应用 | |
| WO2011078351A1 (ja) | 分泌シグナル配列およびこれを利用したタンパク質発現系 | |
| CN114480345B (zh) | MazF突变体、重组载体、重组工程菌及其应用 | |
| WO2004078967A1 (ja) | 麹菌由来ホスホリパーゼa2 | |
| EP1971685B1 (en) | A method for developing a tissue proteome library | |
| US8067552B2 (en) | Method for preparing a target protein using the sHSPs | |
| WO2004016792A1 (ja) | 低温での組み換えタンパク質の発現に適した新規発現ベクター | |
| EP0894864A1 (en) | Genes encoding enzymes of the ACDH-family in plants and methods for producing transgenic seeds or plants with enhanced content or altered compsition of fatty acids and/or amino acids | |
| US6482646B1 (en) | Plant proteins that interact with nuclear matrix proteins and function as transcriptional activators | |
| CN109777808A (zh) | 一种多肽及其在细胞核和叶绿体中定位表达外源蛋白的应用 | |
| RU2415940C1 (ru) | ПЛАЗМИДНЫЙ ВЕКТОР pE-Lc-LTP, ШТАММ БАКТЕРИИ Escherichia coli ДЛЯ ЭКСПРЕССИИ ЛИПИД-ТРАНСПОРТИРУЮЩИХ БЕЛКОВ ЧЕЧЕВИЦЫ Lens culinaris И СПОСОБ ПОЛУЧЕНИЯ УКАЗАННЫХ БЕЛКОВ | |
| EP1176206A2 (en) | Barley DEAD box protein HVD1 gene induced by salt stress | |
| KR100655493B1 (ko) | 작은 열 충격 단백질을 이용한 목적단백질의 제조방법 | |
| Close | Cloning and molecular characterization of two nuclear genes for Zea mays mitochondrial chaperonin 60 | |
| JPH09275986A (ja) | 新規なプロトポルフィリノーゲンオキシダーゼ | |
| Blanchard | Expression and Partial Purification of Several Truncated Forms of Chloroplast Translational Initiation Factor 2 from Euglena Gracilis | |
| Lin et al. | heat shock protein A (HspA), which possesses an intrinsic ability to reactivate inactivated proteins | |
| McIntosh | Characterization of the two genes encoding cytoplasmic ribosomal protein L23a in Arabidopsis thaliana | |
| JP2002058493A (ja) | 細胞死を抑制する植物遺伝子 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060920 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20061220 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20061220 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070912 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20071206 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080512 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20080812 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080815 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20080912 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080918 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20081007 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20081007 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20090126 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20090220 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120227 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120227 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130227 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140227 Year of fee payment: 5 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |